Wave Life Sciences Ltd. (WVE) concluded trading on Wednesday at a closing price of $14.90, with 17.29 million shares of worth about $257.59 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 211.06% during that period and on October 16, 2024 the price saw a gain of about 74.07%. Currently the company’s common shares owned by public are about 154.93M shares, out of which, 120.11M shares are available for trading.
Stock saw a price change of 77.17% in past 5 days and over the past one month there was a price change of 160.95%. Year-to-date (YTD), WVE shares are showing a performance of 195.05% which increased to 166.55% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.50 but also hit the highest price of $9.92 during that period. The average intraday trading volume for Wave Life Sciences Ltd. shares is 1.22 million. The stock is currently trading 79.28% above its 20-day simple moving average (SMA20), while that difference is up 121.47% for SMA50 and it goes to 158.02% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wave Life Sciences Ltd. (NASDAQ: WVE) currently have 154.93M outstanding shares and institutions hold larger chunk of about 65.24% of that.
The stock has a current market capitalization of $2.31B and its 3Y-monthly beta is at -1.12. It has posted earnings per share of -$0.58 in the same period. It has Quick Ratio of 0.99 while making debt-to-equity ratio of 6.56. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for WVE, volatility over the week remained 9.68% while standing at 9.05% over the month.
Stock’s fiscal year EPS is expected to drop by -87.65% while it is estimated to increase by 2.52% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Raymond James on Oct-17-24 offering a Strong buy rating for the stock and assigned a target price of $22 to it. Coverage by JP Morgan stated Wave Life Sciences Ltd. (WVE) stock as an Overweight in their note to investors on September 27, 2024, suggesting a price target of $13 for the stock. On September 19, 2024, B. Riley Securities Initiated their recommendations, while on September 09, 2024, JP Morgan Initiated their ratings for the stock with a price target of $10. Stock get an Overweight rating from Wells Fargo on May 15, 2024.
